These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 10649495)

  • 41. Linkage disequilibrium of common Gaucher disease mutations with a polymorphic site in the pyruvate kinase (PKLR) gene.
    Rockah R; Narinsky R; Frydman M; Cohen IJ; Zaizov R; Weizman A; Frisch A
    Am J Med Genet; 1998 Jul; 78(3):233-6. PubMed ID: 9677056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P).
    Brown JT; Lahey C; Laosinchai-Wolf W; Hadd AG
    BMC Med Genet; 2006 Aug; 7():69. PubMed ID: 16887033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular screening of Japanese patients with Gaucher disease: phenotypic variability in the same genotypes.
    Kawame H; Maekawa K; Eto Y
    Hum Mutat; 1993; 2(5):362-7. PubMed ID: 8257989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease.
    Tayebi N; Stubblefield BK; Park JK; Orvisky E; Walker JM; LaMarca ME; Sidransky E
    Am J Hum Genet; 2003 Mar; 72(3):519-34. PubMed ID: 12587096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and molecular aspects of Gaucher disease in New Zealand.
    Woodfield MJ; Woodfield DG; Winship IM
    N Z Med J; 1997 Aug; 110(1050):316-9. PubMed ID: 9315031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Biochemical and genetic diagnosis of Gaucher disease and its phenotypical heterogeneity].
    Beĭer EM; Bukina TM; Tsvetkova IV
    Vopr Med Khim; 2000; 46(5):451-4. PubMed ID: 11204625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Genetics of Gaucher's disease. Genotype-phenotype correlation].
    Alfonso Palacín P; Pocoví M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():17-22. PubMed ID: 22230121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [From gene to disease; Gaucher disease].
    Hollak CE; Boot RG; Poorthuis BJ; Aerts JM
    Ned Tijdschr Geneeskd; 2005 Sep; 149(39):2163-6. PubMed ID: 16223076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value.
    Boot RG; Hollak CE; Verhoek M; Sloof P; Poorthuis BJ; Kleijer WJ; Wevers RA; van Oers MH; Mannens MM; Aerts JM; van Weely S
    Hum Mutat; 1997; 10(5):348-58. PubMed ID: 9375849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients.
    Amaral O; Marcão A; Sá Miranda M; Desnick RJ; Grace ME
    Eur J Hum Genet; 2000 Feb; 8(2):95-102. PubMed ID: 10757640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
    Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA analysis of an uncommon missense mutation in a Gaucher disease patient of Jewish-Polish-Russian descent.
    Choy FY; Wei C; Applegarth DA; McGillivray BC
    Am J Med Genet; 1994 Jun; 51(2):156-60. PubMed ID: 7916532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.
    Atrian S; López-Viñas E; Gómez-Puertas P; Chabás A; Vilageliu L; Grinberg D
    Proteins; 2008 Feb; 70(3):882-91. PubMed ID: 17803231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Type 2 Gaucher disease: the collodion baby phenotype revisited.
    Stone DL; Carey WF; Christodoulou J; Sillence D; Nelson P; Callahan M; Tayebi N; Sidransky E
    Arch Dis Child Fetal Neonatal Ed; 2000 Mar; 82(2):F163-6. PubMed ID: 10685993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional characterization of the novel mutation IVS 8 (-11delC) (-14T>A) in the intron 8 of the glucocerebrosidase gene of two Italian siblings with Gaucher disease type I.
    Romano M; Danek GM; Baralle FE; Mazzotti R; Filocamo M
    Blood Cells Mol Dis; 2000 Jun; 26(3):171-6. PubMed ID: 10950936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular genetic approaches to neurologic diseases].
    Tsuji S
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1550-3. PubMed ID: 2698300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular analysis of Gaucher disease in a Vietnamese-Czechoslovak patient with high residual glucocerebrosidase activity.
    Choy FY; Woo M; Der Kaloustian VM
    Am J Med Genet; 1991 Jun; 39(4):466-71. PubMed ID: 1877626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of nonsense-mediated mRNA decay in mutant alleles identified in Spanish Gaucher disease patients.
    Montfort M; Chabás A; Vilageliu L; Grinberg D
    Blood Cells Mol Dis; 2006; 36(1):46-52. PubMed ID: 16326120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transient expression of wild-type and mutant glucocerebrosidases in hybrid vaccinia expression system.
    Hodanová K; Melková Z; Horowitz M; Hrebícek M
    Eur J Hum Genet; 2003 May; 11(5):369-74. PubMed ID: 12734541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.